Skip to main content

Latest SEC Filings — Page 95

Page 95 · 30 filings scored 7+ · newest 5:01 PM ET · How scores work

Fri, Oct 1630 filings
8VCIGVCI Global LtdVCI Global H1 2026: Revenue Collapses 86% to US$2.6M, Swings to US$8.4M Net LossForm 6-K · Current report▼ NegativePro8BAOSBaosheng Media Group Holdings LtdBaosheng Posts $19.2M H1 Loss, Going-Concern Doubt, Nasdaq Deficiency NoticeForm 6-K · Current report▼ NegativePro8TGLTreasure Global IncTreasure Global Seeks 1-for-2 to 1-for-50 Reverse Split to Avoid Nasdaq DelistingPRE 14A · Proxy▼ NegativePro7NBNioCorp Developments LtdNioCorp 8-K Details 15-Year Traxys Offtake: 50% Ferroniobium Take-or-Pay, All Other Products ExclusiveForm 8-K · Current report▲ Positive8CGCCanopy Growth CorpCanopy Growth Gets Nasdaq Minimum-Bid Notice; 180 Days to April 12, 2027Form 8-K · Current report▼ NegativePro8IONQIonQ, Inc.IonQ Closes $2B Offering: 20.5M Shares at $40, Plus 129.5M WarrantsForm 8-K · Current report● NeutralPro8PMCBPharmaCyte Biotech, Inc.PharmaCyte Fires Auditor CBIZ, Hires Grassi Amid Material Weaknesses and Nasdaq Delisting RiskForm 8-K · Current report▼ NegativePro7OMHOhmyhome LtdOhmyhome Raises $3.9M in Regulation S Private Placement With Attached WarrantsForm 6-K · Current report▼ Negative7ELPWElong Power Holding Ltd.Elong Power Seeks Shareholder Vote to Move Domicile from Cayman Islands to BVIForm 6-K · Current report● Neutral7AAAlcoa CorpAlcoa: South32 Shareholders Approve $4.1B Deal; $300M+ Locked Box ValueForm 425 · Proxy▲ Positive7BNKKBONK, INC.Bonk Proxy Seeks 70% Equity Plan Increase; Insiders Control 64% of CommonPRE 14A · Proxy▼ Negative8GPATGP-Act III Acquisition Corp.GP-Act III Calls EGM to Extend Deadline to May 8, 2027 for Aerospace Cargo Drone DealPRE 14A · Proxy● NeutralPro7LYVLive Nation Entertainment, Inc.Live Nation Closes $730M/€600M Notes Deal, Cuts Blended Rate to 5.89% and Extends Revolver to 2031Form 8-K · Current report▲ Positive8LASELaser Photonics CorpLaser Photonics Replaces CEO: Founder Nikitin Takes Executive Chairman RoleForm 8-K · Current report▼ NegativePro8TCXBTCGX Acquisition Corp. IITCGX Acquisition Corp. II Prices $100M IPO With Going-Concern WarningForm 424B4 · Offering● NeutralPro9CDTCDT Equity Inc.CDT Equity Sets Nov 12 Vote on J.J. Astor Note Conversion and Reverse SplitPRE 14A · Proxy▼ NegativePro7BMEZBlackRock Health Sciences Term TrustBMEZ Launches Tender Offer for 5% of Shares at 98% of NAV, Expires Nov 18Schedule TO-I● Neutral7TPSTTempest Therapeutics, Inc.Tempest Asks Shareholders to Unlock $50M Lincoln Park Line and 6.4M PIPE Warrant SharesPRE 14A · Proxy▼ Negative7IBEXIBEX LtdIBEX Proxy Seeks 1M-Share LTIP Increase and Lower Bye-Law Vote ThresholdPRE 14A · Proxy● Neutral7VBIOValion Bio, Inc.Valion Bio Seeks New 1-for-2 to 1-for-12 Reverse Split and 272,000-Share Plan IncreaseDEF 14A · Proxy▼ Negative7CALCCalciMedica, Inc.CalciMedica CFO Stephen Bardin Resigns; Departure Effective After Q3 10-Q FilingForm 8-K · Current report▼ Negative7TCRXTScan Therapeutics, Inc.Two TScan Directors Resign Simultaneously as Cash-Strapped Biotech RestructuresForm 8-K · Current report▼ Negative9AAMEAtlantic American CorporationAtlantic American Files Long-Delayed FY2025 10-K: $6.0M Net Income, Three Material Weaknesses, Nasdaq Delisting RiskForm 10-K · Periodic report▼ NegativePro7DAICCID Holdco, Inc.CID Holdco Settles $368K Executive Debt With 808,502 Shares at $6.00 Deemed PriceForm 8-K · Current report● Neutral7BULLWebull CorpWebull Registers 12.3M Pi Acquisition Shares for Resale, Creating Tradable OverhangForm 424B3 · Offering▼ Negative9SAFXXCF Global, Inc.10% Owner EEME Energy Buys $142M of XCF Global Stock at $1.19/ShareForm 4 · Insider trade▲ PositivePro8NKLRTerra Innovatum Global N.V.Terra Innovatum Dismisses KPMG as Auditor, Taps MaloneBailey; Material Weaknesses UnremediatedForm 8-K · Current report▼ NegativePro8NGENNervGen Pharma Corp.NervGen Refiles Q2 2026 Interim Financials, Restating Loss to Income on Warrant FixForm 6-K/A · Current report▼ NegativePro8CTWCTWCTW 20-F: FY26 Revenue Falls 8.7% to $82.5M, Net Loss $4.1M, Material Weakness DisclosedForm 20-F · Periodic report▼ NegativePro8NGENNervGen Pharma Corp.NervGen Files Amended 40-F with Restated Financials and Material Weakness DisclosureForm 40-F/A · Periodic report▼ NegativePro
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.